About Uro Chart
Uro Chart was a Healthcare company based in Springfield (United States) founded in 2005 by Howard Follis. It provides EHR software specialized for urology practices. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Medical Software, EHR Systems and Urology Solutions. Its competitors include Urolee, UroScribe and Nephrologixx.
Company details
Uro Chart, established in 2005 and currently in Dissolved stage, focuses on providing healthcare solutions, medical software, ehr systems, and urology solutions. Provides EHR software specialized for urology practices. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Springfield, United States
- Founders Howard Follis
- SectorsHealthcare
- Website urochartemr.com
People of Uro Chart
1 people are tracked at Uro Chart (1 in leadership).
| Name | Role | Group |
|---|---|---|
Howard Follis | Founder | Leadership |
Complete people profiles for Uro Chart
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Uro Chart
Uro Chart has 3 listed competitors in our database. They include Urolee, UroScribe and Nephrologixx.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| urolee.com | 2020 | Tampa, United States | Delivers practice management software specifically for urologists. | |||
| uroscribe.com | 2019 | Little Rock, United States | Medical scribe program for urologists to manage patient documentation and reduce EHR tasks. | |||
| nephrologixx.com | 2015 | Nashville, United States | Provides software for benchmarking and optimizing nephrology practices effectively. |
Detailed competitors of Uro Chart
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genitourinary Disorders
3 companies that operate in the same segment as Uro Chart (Genitourinary Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction | 2012 | Malvern, Pennsylvania, United States | USD 104.6 M | USD 80.28 M | 209 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Uro Chart
Uro Chart was founded in 2005.
Uro Chart is headquartered in Springfield, United States.
Uro Chart, established in 2005 and currently in Dissolved stage, focuses on providing healthcare solutions, medical software, ehr systems, and urology solutions. Provides EHR software specialized for urology practices. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
Uro Chart's top competitors include Urolee, UroScribe and Nephrologixx.